Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on SGRY shares. Royal Bank of Canada reduced their target price on shares of Surgery Partners from $65.00 to $62.00 and set an "outperform" rating for the company in a report on Wednesday, August 3rd. Benchmark raised their target price on Surgery Partners from $65.00 to $72.00 in a report on Wednesday, May 4th. StockNews.com cut Surgery Partners from a "hold" rating to a "sell" rating in a research report on Tuesday, July 26th. Bank of America cut shares of Surgery Partners from a "buy" rating to a "neutral" rating and cut their target price for the stock from $55.00 to $36.00 in a research note on Wednesday, June 15th. Finally, Citigroup raised their price target on shares of Surgery Partners from $61.00 to $64.00 in a research note on Wednesday, May 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $58.67.
Surgery Partners Stock Up 0.3 %
Shares of SGRY Stock traded up $0.10 during trading on Monday, hitting $37.00. 183,134 shares of the company were exchanged, compared to its average volume of 484,174. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.39 and a current ratio of 1.51. Surgery Partners has a twelve month low of $26.66 and a twelve month high of $63.87. The business's 50-day simple moving average is $33.85 and its 200 day simple moving average is $44.22.
Insider Buying and Selling
In other news, insider George Goodwin sold 12,586 shares of the company's stock in a transaction that occurred on Monday, June 6th. The stock was sold at an average price of $40.00, for a total value of $503,440.00. Following the sale, the insider now directly owns 31,806 shares in the company, valued at approximately $1,272,240. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In the last 90 days, insiders sold 26,380 shares of company stock valued at $1,053,599. Insiders own 3.30% of the company's stock.